Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07750717

Bedside Spirometry for Acute Lung Injury

The diagnosis of Acute Respiratory Distress Syndrome (ARDS) is a syndromic diagnosis that groups together patients who may have very different prognoses and respond differently to the same therapies.

Additionally, non-invasive ventilation (NIV) has shown highly contrasting results in the early management of ARDS. One of the predictive criteria for NIV failure is an excessively high tidal volume during non-invasive ventilation.

SPIRALI is a pilot study evaluating the relevance of a respiratory physiology parameter, the tidal volume relative to the theoretical ideal body weigh, in the phenotypic classification of non-intubated ARDS patients. In this initial approach, the investigators will compare the tidal volume during high-flow oxygen therapy with the tidal volume obtained under NIV (after applying a settings optimization algorithm). The investigators hypothesize that if tidal volume is linked to each situation, the same patients will exhibit a high tidal volume both during spontaneous ventilation and under NIV.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Centre Hospitalier Universitaire de Nantes - Hôpital Hôtel Dieu

Nantes, 44093, France

Location contact

Jean Baptiste LASCARROU, Dr

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient over 18 years of age;
  • Patient hospitalized in intensive care for less than 24 hours;
  • Patient with severe hypoxemic acute respiratory failure characterized by a PaO2/FiO2 ratio < 300 mmHg and > 150 mmHg under high-flow oxygen therapy at 60 L/min;
  • Patient able to cooperate with the spirometry test;
  • Patient able to follow the protocol and having given their informed written consent to participate in the study;
  • Patient affiliated with the social security system or entitled to benefits;

Exclusion criteria

  • Patients with an indication for intubation;
  • Patients with a contraindication for or who refuse NIV;
  • Patients with hemodynamic instability requiring vasopressor support greater than 0.25 μg/kg/min of norepinephrine;
  • Patients with a Glasgow score < 15;
  • Patients with hypercapnia (PaCO2 > 45 mmHg);
  • Patients with a PaO2/FiO2 ratio < 150 mmHg;
  • Patients with cardiogenic pulmonary edema;
  • Patients who have already undergone a session of NIV in intensive care during this stay;
  • Patients with chronic respiratory failure (home oxygen therapy or home non-invasive ventilation (excluding indications solely for sleep apnea syndrome));
  • Patients who have recently had a pneumothorax;
  • Patients who have recently undergone eye surgery (e.g., cataract surgery) or throat surgery;
  • Patients with significant arterial disease: recent heart attack, pulmonary embolism, poorly controlled hypertension despite treatment, etc.
  • Patients already included in the study;
  • Pregnant women, women in labor, or women who are breastfeeding;
  • Patients under guardianship, conservatorship, or deprived of their liberty;
  • Patients under an activated future protection mandate;
  • Patients under family authorization;
  • Patients under judicial protection;

Treatment and study plan

Hand-held spirometer

Device

spontaneous ventilation using a hand-held spirometer

NIV

Device

NIV with predefined settings and then with optimized settings

Primary outcomes

  1. Show a correlation between the tidal volume measurement in spontaneous ventilation and the tidal volume measurement in NIV

    Time frame: At T2 and T3, with measurement of VT using a portable spirometer and NIV on the day of enrollment. T1,T2,T3<1h30min

    Tidal volume measured by a hand-held spirometer in spontaneous ventilation and exhaled tidal volume measured by the ventilator in NIV after optimization of the settings

Study contacts

Contact information is provided by the study sponsor or research team.

Laura SOULARD

CONTACT

[email protected]

02.51.08.05.82 ext. +33

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Departemental Vendee

Other

Registry information

Official study title

Correlation Between Tidal Volume in Spontaneous Ventilation and Tidal Volume in Non-invasive Ventilation in Acute Hypoxemic Non-hypercapnic Respiratory Failure

Acronym: SPIRALI

Important dates

Study start
2026
Primary completion
2026
Study completion
2029
First posted
Aug 6, 2026
Registry last updated
Aug 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.